Pre-Salpingo-Oophorectomy Pilot Study of MAKO 7 Device Performance
Cytological Evaluation of Specimens Collected With the MAKO 7 Device in Pre Salpingo-Oophorectomy Subjects for Determination and/or Differentiation of Normal Versus Atypical Versus Malignant Cells
Sponsor: nVision Medical
This observational or N/A phase trial investigates Atypia Suspicious for Malignancy and BRCA1 Mutation and is currently completed. nVision Medical leads this study, which shows 17 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
17 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 12 earlier versions
-
May 2020 — Nov 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Dec 2019 — May 2020 [monthly]
Active Not Recruiting
-
Aug 2019 — Dec 2019 [monthly]
Active Not Recruiting
-
Apr 2019 — Aug 2019 [monthly]
Active Not Recruiting
-
Aug 2018 — Apr 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Aug 2017 — Oct 2017 [monthly]
Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- nVision Medical
For direct contact, visit the study record on ClinicalTrials.gov .